Host- and disease-specific factors affecting steatosis in chronic hepatitis C

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 198-206

  Czaja, Albert J ^a   Carpenter, Herschel A ^a   Santrach, Paula J ^a   Breanndan Moore, S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hepatitis C; Risk factors; Steatosis

Indexed keywords

ANTINUCLEAR ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HOST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STEATOSIS;

EID: 0032146915     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80004-4     Document Type: Article

References (46)

1. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology. 15:1992;567-571.
2. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology. 15:1992;572-577.
3. Roberts JM, Searle JW, Cooksley WG. Histological patterns of prolonged hepatitis C infection. Gastroenterologia Japonica. 5:1993;37-41. (suppl).
4. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis. 15:1995;70-81.
5. Fischer HP, Willsch E, Bierhoff E, Pfeifer U. Histopathologic findings in chronic hepatitis C. J Hepatol. 24:1996;35-42.
6. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 105:1993;1824-1832.
7. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 12:1990;1106-1110.
8. Hodgson M, Van Thiel DH, Goodman-Klein B. Obesity and hepatotoxins as risk factors for fatty liver disease. Br J Indust Med. 48:1991;690-695.
9. Samarasinghe D, Tasman-Jones C. The clinical associations with hepatic steatosis: a retrospective study. NZ Med J. 105:1992;57-58.
10. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 126:1997;137-145.
11. Czaja AJ, Carpenter HA. Histological findings in chronic hepatitis C with autoimmune features. Hepatology. 26:1997;459-466.
12. VanItallie TB. Prevalence of obesity. Endocrinol Metab Clin North Am. 25:1996;887-905.
13. Forrester T, Wilks R, Bennett F, McFarlane-Anderson N, McGee D, Cooper R, et al. Obesity in the Caribbean. Ciba Foundation Symposium. 201:1996;17-31.
14. National Center for Health Statistics: Health, United States, 1994. Hyattsville, MD, Public Health Service. DHHS Pub. No. (PHS) 95-1232; 1995. p. 165.
15. Measuring Obesity: Classification and Description of Anthropometric Data. 1989;World Health Organization, Copenhagen.
16. Metropolitan height and weight tables. Stat Bull Metropol Life Insur Co. 64:1983;2.
17. Wood JR, Czaja AJ, Taswell HF, Ludwig J, Rakela J, Chase R. Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B. Gastroenterology. 93:1987;1225-1230.
18. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 24:1996;1068-1073.
19. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology. 103:1992;1290-1295.
20. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology. 18:1993;816-822.
21. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
22. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
23. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histologic grading and staging of chronic hepatitis. J Hepatol. 22:1995;696-699.
24. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 25:1997;317-323.
25. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol. 78:1997;1527-1531.
26. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 22:1995;449-456.
27. Fiore G, Fera G, Napoli N, Vella F, Schiraldi O. Liver steatosis and chronic hepatitis C: a spurious association? Eur J Gastroenterology Hepatology. 8:1996;125-129.
28. Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology. 25:1997;735-739.
29. McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology. 23:1996;676-687.
30. Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med. 154:1994;2733-2736.
31. Czaja AJ. HLA DR11 and DR12 in chronic hepatitis C: reply to Zavaglia et al [letter]. J Hepatol. 27:1997;249.
32. Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, et al. Influence of HLA haplotypes on the clinical courses of individuals infected with the hepatitis C virus. Hepatology. 27:1998;240-244.
33. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in Northern European Caucasoids. Hepatology. 24:1996;1342-1345.
34. Alric L, Fort M, Izopet J, Vinel J-P, Charlet J-P, Selves J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology. 113:1997;1675-1681.
35. Bouchard C, Perusse L, Leblanc C, Tremblay a, Theriault G. Inheritance of the amount and distribution of human body fat. Int J Obesity. 12:1988;205-215.
36. Sorensen TIA. The genetics of obesity. Metabolism. 44:1995;4-6.
37. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
38. Grove J, Daly AK, Bassendine M, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 26:1997;143-146.
39. Gonzalez-Peralta RP, Davis GL, Lau JYN. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol. 21:1994;255-259.
40. Dienes HP, Popper H, Arnold W, Lobeck H. Histological observations in human hepatitis non-A, non-B hepatitis. Hepatology. 2:1982;552-571.
41. Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, Mori C, et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology. 16:1992;306-311.
42. Romeo R, Pol S, Berthelot P, Brechot C. Eradication of hepatitis C virus RNA after alpha-interferon therapy. Ann Intern Med. 121:1994;276-277.
43. Mosnier J-F, Degott C, Marcellin P, Henin D, Erlinger S, Benhamou J-P. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology. 17:1993;366-371.
44. Mosnier J-F, Scoazec J-Y, Marcellin P, Degott C, Benhamou J-P, Feldmann G. Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology. 107:1994;1457-1468.
45. Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med. 178:1993;17-25.
46. Tran A, Benzaken S, Yang G, Schneider S, Doglio A, Rampal A, et al. Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment. Dig Dis Sci. 42:1997;778-780.